红外热图Hash值评估度洛西汀治疗持续性躯体形式疼痛障碍的效用评价

曾霜; 邹卓杉; 唐俊童; 范真珍; 崔剑

doi:10.16016/j.2097-0927.202301072

您当前的位置：

首页 >

文章列表页 >

红外热图Hash值评估度洛西汀治疗持续性躯体形式疼痛障碍的效用评价

临床医学 | 更新时间：2026-01-09

- 红外热图Hash值评估度洛西汀治疗持续性躯体形式疼痛障碍的效用评价
- Efficacy of Hash value in infrared thermogram in assessment of duloxetine for persistent somatoform pain disorder
- 陆军军医大学学报 2023年45卷第20期页码：2141-2148
- 作者机构：
  
  400038 重庆，陆军军医大学(第三军医大学)第一附属医院疼痛科
- 作者简介：
  
  [崔剑，E-mail：cqjian211@163.com CUI Jian, E-mail: cqjian211@163.com
- 基金信息：
  
  国家自然科学基金面上项目(81870883)
- DOI：10.16016/j.2097-0927.202301072
  中图分类号： R445.7;R749.2;R971.2
- 收稿：2023-01-14，
  
  修回：2023-03-28，
  
  纸质出版：2023-10-30
- 稿件说明：
移动端阅览
曾霜, 邹卓杉, 唐俊童, 等. 红外热图Hash值评估度洛西汀治疗持续性躯体形式疼痛障碍的效用评价[J]. 陆军军医大学学报, 2023,45(20):2141-2148.

Shuang ZENG, Zhuoshan ZOU, Juntong TANG, et al. Efficacy of Hash value in infrared thermogram in assessment of duloxetine for persistent somatoform pain disorder[J]. Journal of Army Medical University, 2023, 45(20): 2141-2148.
曾霜, 邹卓杉, 唐俊童, 等. 红外热图Hash值评估度洛西汀治疗持续性躯体形式疼痛障碍的效用评价[J]. 陆军军医大学学报, 2023,45(20):2141-2148. DOI： 10.16016/j.2097-0927.202301072.

Shuang ZENG, Zhuoshan ZOU, Juntong TANG, et al. Efficacy of Hash value in infrared thermogram in assessment of duloxetine for persistent somatoform pain disorder[J]. Journal of Army Medical University, 2023, 45(20): 2141-2148. DOI： 10.16016/j.2097-0927.202301072.

摘要

目的

对医用红外热图分析中的差异哈希算法(Hash function，Hash值)评估度洛西汀治疗持续性躯体形式疼痛障碍(persistent somatoform pain disorder，PSPD)的效用进行再评价。

方法

选取2022年2-12月在我科门诊诊断为PSPD并接受度洛西汀药物治疗的70例患者，收集治疗前，治疗后4、8、12周的红外热图Hash值、疼痛视觉模拟评分(visual analogue scale，VAS)、汉密尔顿焦虑量表14项评分(hamilton anxiety scale-14，HAMA-14)、HAMD-17、匹兹堡睡眠质量指数量表评分(Pittsburgh sleep quality index，PSQI)、健康问卷躯体症状群量表15项评分(patient health questionnaire-15，PHQ-15)、症状自评量表90项评分(symptom checklist-90，SCL-90)，采用Spearman分析红外热图Hash值与VAS、HAMA-14、HAMD-17、PSQI、PHQ-15、SCL-90量表评分的相关性，同时记录对比各时间点疼痛缓解率、药物不良反应等。

结果

70例PSPD患者经度洛西汀治疗后4、8、12周疼痛缓解率分别为31.43%、67.14%、78.57%。与治疗前比较，红外热图Hash值随治疗时间的进展呈上升趋势(

=0.000)，而VAS、HAMA-14、HAMD-17、PSQI、PHQ-15和SCL-90量表评分均随治疗时间的进展呈下降趋势(

=0.000)。治疗前及治疗后4、8、12周的红外热图Hash值与VAS评分的相关系数

分别为-0.457、-0.313、-0.609、-0.696，与HAMA-14评分的相关系数

分别为-0.597、-0.433、-0.524、-0.629，与HAMD-17评分的相关系数

分别为-0.677、-0.315、-0.319、-0.448，与PSQI评分的相关系数

分别为-0.462、-0.284、-0.361、-0.446，与PHQ-15评分的相

关系数

分别为-0.542、-0.357、-0.455、-0.620，与SCL-90评分的相关系数

分别为-0.485、-0.402、-0.483、-0.516。治疗12周后与治疗前红外热图Hash值差值及VAS、HAMA-14、HAMD-17、PSQI、PHQ-15、SCL-90量表评分差值的相关系数

分别为-0.734、-0.429、-0.461、-0.314、-0.369、-0.293。

结论

红外热图Hash值可以作为一种辅助诊断PSPD和治疗后效果评价的客观指标。

Abstract

Objective

To investigate the efficacy of Hash value in medical infrared thermogram analysis for assessing the therapeutic effect of duloxetine on persistent somatoform pain disorder (PSPD).

Methods

A total of 70 PSPD patients treated with duloxetine medication in our outpatient clinic from February 2022 to December 2022 were enrolled in this study. Hash value in infrared thermogram

visual analogue scale (VAS) score

and results of Hamilton Anxiety Scale-14 (HAMA-14)

Hamilton Depression Scale-17 (HAMD-17)

Pittsburgh Sleep Quality Index (PSQI)

Patient Health Questionnaire-15 (PHQ-15) and Symptom Checklist-90 (SCL-90) were collected before and 4

8 and 12 weeks after treatment. Spearman correlation analysis was used to analyze the correlation between the Hash value with the scores of above scales and questionnaires. The pain relief rate and adverse reactions were also recorded and analyzed.

Results

The pain relief rate was 31.43%

67.14% and 78.57%

respectively in 4

8 and 12 weeks after duloxetine treatment. In comparison with the values before treatment

the Hash value was in a trend of increasing with the progression of treatment time (

=0.000)

while the results of VAS

HAMA-14

HAMD-17

PSQI

PHQ-15 and SCL-90 all showed a decreasing trend during the period (

=0.000). The correlation coefficient

between the Hash value in infrared thermogram and VAS score was -0.457

-0.313

-0.609 and -0.696

respectively before and 4

8 and 12 weeks after treatment; And the correlat

ion coefficient

with HAMA-14 score was -0.597

-0.433

-0.524 and -0.629

respectively; that with HAMD-17 score was -0.677

-0.315

-0.319 and -0.448 respectively; that with PSQI score was -0.462

-0.284

-0.361 and -0.446 respectively; that with PHQ-15 score was -0.542

-0.357

-0.455 and -0.620 respectively; and that with SCL-90 score was -0.485

-0.402

-0.483 and -0.516

respectively at the corresponding time points. The correlation coefficient

of the difference between the infrared thermogram Hash value and the score difference of VAS

HAMA-14

HAMD-17

PSQI

PHQ-15 and SCL-90 in 12 weeks after treatment and before treatment was -0.734

-0.429

-0.461

-0.314

-0.369 and -0.293

respectively.

Conclusion

Hash value in infrared thermogram can be used as an objective indicator in the adjuvant diagnosis of PSPD and evaluation of treatment efficacy.

关键词

Keywords

references

LIU Q, ZENG X C, JIANG X M, et al . Altered brain functional hubs and connectivity underlie persistent somatoform pain disorder[J ] . Front Neurosci, 2019, 13: 415. DOI: 10.3389/fnins.2019.00415.

BRANSFIELD, FRIEDMAN. Differentiating psychosomatic, somatopsychic, multisystem illnesses, and medical uncertainty[J]. Healthcare, 2019, 7(4): 114. DOI: 10.3390/healthcare7040114.

CAO J Y, WEI J, FRITZSCHE K, et al . Prevalence of DSM-5 somatic symptom disorder in Chinese outpatients from general hospital care[J ] . Gen Hosp Psychiatry, 2020, 62: 63-71. DOI: 10.1016/j.genhosppsych.2019.11.010.

KLEINSTÄUBER M, WITTHÖFT M, STEFFANOWSKI A, et al . Pharmacological interventions for somatoform disorders in adults[J ] . Cochrane Database Syst Rev, 2014(11): CD010628. DOI: 10.1002/14651858.cd010628.pub2.

VAN DESSEL N, DEN BOEFT M, VAN DER WOUDEN J C, et al . Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults[J ] . Cochrane Database Syst Rev, 2014(11): CD011142. DOI: 10.1002/14651858.CD011142.pub2.

RUSSELL I J, MEASE P J, SMITH T R, et al . Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial[J ] . Pain, 2008, 136(3): 432-444. DOI: 10.1016/j.pain.2008.02.024.

瞿伟, 谷珊珊, 罗菡, 等. 奥氮平联合氟西汀与度洛西汀治疗躯体形式疼痛障碍的疗效比较[J]. 第三军医大学学报, 2012, 34(6): 555-557.

QU W, GU S S, LUO H, et al . Efficacy comparison between olanzapine-fluoxetine combination and duloxetine in treatment of somatoform pain disorder[J ] . J Third Mil Med Univ, 2012, 34(6): 555-557.

LAW J, CHALMERS J, MORRIS D E, et al . The use of infrared thermography in the measurement and characterization of brown adipose tissue activation[J ] . Temperature, 2018, 5(2): 147-161. DOI: 10.1080/23328940.2017.1397085.

POLIDORI G, KINNE M, MEREU T, et al . Medical Infrared Thermography in back pain osteopathic management[J ] . Complementary Ther Med, 2018, 39: 19-23. DOI: 10.1016/j.ctim.2018.05.010.

BALBINOT L F, CANANI L H, ROBINSON C C, et al . Plantar thermography is useful in the early diagnosis of diab etic neuropathy[J ] . Clinics (Sao Paulo), 2012, 67(12): 1419-1425. DOI: 10.6061/clinics/2012(12)12.

GATENHOLM B, BRITTBERG M. Neuropeptides: important regulators of joint homeostasis[J]. Knee Surg Sports Traumatol Arthrosc, 2019, 27(3): 942-949. DOI: 10.1007/s00167-018-5074-4.

EDDY A L, VAN HOOGMOED L M, SNYDER J R. The role of thermography in the management of equine lameness[J]. Vet J, 2001, 162(3): 172-181. DOI: 10.1053/tvjl.2001.0618.

GROSSBARD B P, LOUGHIN C A, MARINO D J, et al . Medical infrared imaging (thermography) of type Ⅰ thoracolumbar disk disease in chondrodystrophic dogs[J ] . Vet Surg, 2014, 43(7): 869-876. DOI: 10.1111/j.1532-950X.2014.12239.x.

ZOLET C M L S, ULBRICHT L, ROMANELI E F R, et al . Thermal asymmetries and mean foot temperature[C ] //2019 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). July 23-27, 2019. Berlin, Germany. IEEE, 2019: 2821-2824. DOI: 10.1109/embc.2019.8857378.

CHO C W, NAHM F S, CHOI E, et al . Multicenter study on the asymmetry of skin temperature in complex regional pain syn drome[J ] . Medicine, 2016, 95(52): e5548. DOI: 10.1097/md.0000000000005548.

LOUGHIN CATHERINE A, MARINO DOMINIC J. Evaluation of thermographic imaging of the limbs of healthy dogs[J]. Am J Vet Res, 2007, 68(10): 1064-1069.

ALFIERI F M, MASSARO A R, FILIPPO T R, et al . Evaluation of body temperature in individuals with stroke[J ] . NeuroRehabilitation, 2017, 40(1): 119-128. DOI: 10.3233/NRE-161397.

陈军. 慢性疼痛转化研究的困境与挑战[J]. 空军军医大学学报, 2023(2): 97-104. DOI:10.13276/j.issn.2097-1656.2023.04.001.

CHEN J. Dilemma and challenges of translational research on chronic pain[J]. J Air Force Med Univ, 2023(2): 97-104. DOI: 10.13276/j.issn.2097-1656.2023.04.001.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

奥氮平联合氟西汀与度洛西汀治疗躯体形式疼痛障碍的疗效比较